Rapid Diagnostic Testing 2022 - SARS-CoV-2 & Beyond

Overview

SelectBIO welcomes you to the Rapid Diagnostic Testing 2022: SARS-CoV-2 and Beyond Conference to be held on-site in Boston as a regular conference with on-site participants.

This conference brings together researchers from academic institutions and industry who are involved in developing technologies and tools to enable rapid testing at the point-of-care setting.  The ongoing COVID-19 pandemic provides a paradigm for deployment of these tools for rapid testing and drives the need for technology developments in this space.

Participants will address emerging tools and companies developing tools present their tools and approaches.

Professor Peter Ertl will be serving as Conference Chairperson and the format of the conference will include scientific presentations as well as presentations from companies as well as discussions and networking with participants from other co-located conference tracks.

All attendees receive full access to all co-located and concurrent tracks for maximal scientific exchanges and networking opportunities.

The conference is held on-site in Boston as a regular conference with on-site participants and proof of vaccination against COVID-19 is required to attend the event on-site.